WASHINGTON (Reuters) - Researchers have developed a new way to make embryonic-like stem cells by soaking them in genetically engineered proteins, a new step toward using ordinary cells to treat disease.
WASHINGTON (Reuters) - Researchers have developed a new way to make embryonic-like stem cells by soaking them in genetically engineered proteins, a new step toward using ordinary cells to treat disease.
